No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs555271408 |
chr4:3765728-3765729 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs574912380 |
chr4:3765747-3765748 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs13118771 |
chr4:3765755-3765756 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs565137143 |
chr4:3765771-3765772 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs560421687 |
chr4:3765792-3765793 |
Enhancers Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs577264778 |
chr4:3765843-3765844 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs545931230 |
chr4:3765893-3765894 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs76020435 |
chr4:3765918-3765919 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs180770225 |
chr4:3765938-3765939 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs185752032 |
chr4:3765943-3765944 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs76323688 |
chr4:3765977-3765978 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs560832975 |
chr4:3765986-3765987 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs529695362 |
chr4:3765994-3765995 |
Bivalent Enhancer Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs547612755 |
chr4:3766049-3766050 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs28576409 |
chr4:3766054-3766055 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs566294481 |
chr4:3766068-3766069 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs370251216 |
chr4:3766071-3766072 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs551954609 |
chr4:3766126-3766127 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs569497512 |
chr4:3766138-3766139 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs538422121 |
chr4:3766176-3766177 |
Bivalent Enhancer Weak transcription Enhancers
|
CpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs555338703 |
chr4:3766209-3766210 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs559870379 |
chr4:3766212-3766213 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs111271749 |
chr4:3766235-3766236 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs575202431 |
chr4:3766236-3766237 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs6846820 |
chr4:3766265-3766266 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs143633304 |
chr4:3766267-3766268 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs190324456 |
chr4:3766270-3766271 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs116893661 |
chr4:3766329-3766330 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs148087727 |
chr4:3766388-3766389 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs61754810 |
chr4:3766408-3766409 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs543992455 |
chr4:3766433-3766434 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs560894307 |
chr4:3766475-3766476 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs530002938 |
chr4:3766485-3766486 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs540111344 |
chr4:3766509-3766510 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs560106139 |
chr4:3766555-3766556 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs531986442 |
chr4:3766575-3766576 |
Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs75576268 |
chr4:3766642-3766643 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs568959270 |
chr4:3766689-3766690 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs531984980 |
chr4:3766797-3766798 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs74832750 |
chr4:3766821-3766822 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs140988404 |
chr4:3766828-3766829 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs534516855 |
chr4:3766845-3766846 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs554142498 |
chr4:3766861-3766862 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs570852768 |
chr4:3766868-3766869 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs531849472 |
chr4:3766938-3766939 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs144791572 |
chr4:3767064-3767065 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs80277987 |
chr4:3767072-3767073 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs576123005 |
chr4:3767100-3767101 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs577147100 |
chr4:3767133-3767134 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs77962119 |
chr4:3767136-3767137 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|